BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 19390557)

  • 1. Different forms of cell death induced by putative BCL2 inhibitors.
    Vogler M; Weber K; Dinsdale D; Schmitz I; Schulze-Osthoff K; Dyer MJ; Cohen GM
    Cell Death Differ; 2009 Jul; 16(7):1030-9. PubMed ID: 19390557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells.
    Vogler M; Dinsdale D; Sun XM; Young KW; Butterworth M; Nicotera P; Dyer MJ; Cohen GM
    Cell Death Differ; 2008 May; 15(5):820-30. PubMed ID: 18309326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10A and fibroblast cells but affects Bcl-2 antagonist-induced respiratory changes.
    Clerc P; Ge SX; Hwang H; Waddell J; Roelofs BA; Karbowski M; Sesaki H; Polster BM
    Br J Pharmacol; 2014 Apr; 171(8):1988-99. PubMed ID: 24206264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of an ABT-737-sensitive primed for death state in cells using microplate-based respirometry.
    Clerc P; Carey GB; Mehrabian Z; Wei M; Hwang H; Girnun GD; Chen H; Martin SS; Polster BM
    PLoS One; 2012; 7(8):e42487. PubMed ID: 22880001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering Bim and Bak in human pancreatic cancer cells.
    Huang S; Sinicrope FA
    Cancer Res; 2008 Apr; 68(8):2944-51. PubMed ID: 18413764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
    Chen S; Dai Y; Harada H; Dent P; Grant S
    Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-x(L).
    Lindenboim L; Blacher E; Borner C; Stein R
    Cell Death Differ; 2010 Feb; 17(2):346-59. PubMed ID: 19816507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells.
    Jane EP; Premkumar DR; Morales A; Foster KA; Pollack IF
    J Pharmacol Exp Ther; 2014 Jul; 350(1):22-35. PubMed ID: 24741074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
    van Delft MF; Wei AH; Mason KD; Vandenberg CJ; Chen L; Czabotar PE; Willis SN; Scott CL; Day CL; Cory S; Adams JM; Roberts AW; Huang DC
    Cancer Cell; 2006 Nov; 10(5):389-99. PubMed ID: 17097561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak.
    Lindqvist LM; Heinlein M; Huang DC; Vaux DL
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8512-7. PubMed ID: 24912196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak.
    Wang C; Youle RJ
    Oncogene; 2012 Jun; 31(26):3177-89. PubMed ID: 22056880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.
    Pedro JM; Wei Y; Sica V; Maiuri MC; Zou Z; Kroemer G; Levine B
    Autophagy; 2015; 11(3):452-9. PubMed ID: 25715028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization.
    Buron N; Porceddu M; Brabant M; Desgué D; Racoeur C; Lassalle M; Péchoux C; Rustin P; Jacotot E; Borgne-Sanchez A
    PLoS One; 2010 Mar; 5(3):e9924. PubMed ID: 20360986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial fragmentation and neuronal cell death in response to the Bcl-2/Bcl-x(L)/Bcl-w antagonist ABT-737.
    Young KW; Piñón LG; Dhiraj D; Twiddy D; Macfarlane M; Hickman J; Nicotera P
    Neuropharmacology; 2010 Jun; 58(8):1258-67. PubMed ID: 20307556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of ABT-737 and SAHA induces apoptosis, mediated by Noxa upregulation, Bax activation and mitochondrial dysfunction in PTEN-intact malignant human glioma cell lines.
    Foster KA; Jane EP; Premkumar DR; Morales A; Pollack IF
    J Neurooncol; 2014 Dec; 120(3):459-72. PubMed ID: 25139025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
    Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
    Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells.
    Cristofanon S; Fulda S
    Cell Death Dis; 2012 Nov; 3(11):e432. PubMed ID: 23190604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737.
    Sutton VR; Sedelies K; Dewson G; Christensen ME; Bird PI; Johnstone RW; Kluck RM; Trapani JA; Waterhouse NJ
    Cell Death Dis; 2012 Jul; 3(7):e344. PubMed ID: 22764103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.